Key facts
- It has raised $240K; the latest was Seed Round ($240K) in Feb 2026.
- Notable investors include US National Science Foundation.
- Treysta Medical Technologies has filed 2 Form Ds with the SEC since 2025, most recently Feb 2026 ($90K sold to 5 investors).
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Treysta Medical Technologies
- ·The full record, as it builds
Funding rounds
No funding rounds for Treysta Medical Technologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Treysta Medical Technologies
Developer of regenerative treatment systems designed for acute burn care purposes. The company supports early-stage intervention to reduce scarring, fibrosis, and contracture, enabling emergency care providers to improve healing outcomes and enhance survivor quality of life.
- Sector
- Healthcare
- HQ
- Gainesilville, FL, United States
- Founded
- 2025
- Employees
- 4
- Ownership
- Privately Held (backing)
Treysta Medical Technologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Treysta Medical Technologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Treysta Medical Technologies in its N-PORT filings yet. We sweep new filings monthly.